(+) -Tetrabenazine
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


(+) -Tetrabenazine
Description :
(+) -Tetrabenazine ((+) -TBZ; (3R,11bR) -TBZ; (3R,11bR) -Tetrabenazine) is a reversible inhibitor of vesicular monoamine transporter 2 (VMAT-2), inhibits transport by VMAT2 with 10-fold greater potency than transport by VMAT1. target: VMAT-2 In vitro: (+) -Tetrabenazine inhibit the activity of the transporter but appear to interact differently with the protein. [2] (+) -Tetrabenazine inhibits reserpine binding to the transporter, suggesting that the sites may interact in an allosteric manner. [1] In vivo: 0.9% saline (80%) and dimethylsulfoxide (DMSO) (20%) . (+) -Tetrabenazine blocks dopamine (DA) storage and depletes striatal DA; (+) -Tetrabenazine was shown to induce tremulous jaw movements (TJMs) in rats and mice. The reference dose for administration is 2.0 mg/kg.[2]Product Name Alternative :
(+) -TBZ; (3R,11bR) -TBZ; (3R,11bR) -TetrabenazineUNSPSC :
12352005Hazard Statement :
H315, H319, H320Target :
Monoamine TransporterRelated Pathways :
Membrane Transporter/Ion ChannelApplications :
Cancer-programmed cell deathField of Research :
CancerPurity :
98.72Solubility :
DMSO : 16.67 mg/mL (ultrasonic)Smiles :
COC1=C(OC)C=C(CCN(C[C@H]2CC(C)C)[C@]3([H])CC2=O)C3=C1Molecular Formula :
C19H27NO3Molecular Weight :
317.42Precautions :
H315, H319, H320References & Citations :
[1]Podurgiel SJ et al. The MAO-B inhibitor deprenyl reduces the oral tremor and the dopamine depletion induced by the VMAT-2 inhibitor tetrabenazine. Behav Brain Res. 2016 Feb 1;298 (Pt B) :188-91.|[2]Peter D et al. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine. J Biol Chem. 1996 Feb 9;271 (6) :2979-86.Shipping Conditions :
Room TemperatureStorage Conditions :
-20°C, 3 years; 4°C, 2 years (Powder)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedCAS Number :
[1026016-83-0]

